AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
PERTUZUMAB + TRASTUZUMAB
12 registrations across 5 African markets— 12 active
Markets with PERTUZUMAB + TRASTUZUMAB
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| PHESGO | 🇬🇭Ghana | — | active | May 2030 |
| PHESGO | 🇬🇭Ghana | — | active | May 2030 |
| PHESGO 1200MG/600MG SOLUTION INJECTABLE EN SC FLACON DE 10ML | 🇨🇮Côte d'Ivoire | F. HOFFMANN-LA ROCHE LTD | active | Oct 2028 |
| PHESGO 600MG/600MG SOLUTION INJECTABLE EN SC FLACON DE 10ML | 🇨🇮Côte d'Ivoire | F. HOFFMANN-LA ROCHE LTD | active | Oct 2028 |
| PHESGO SOLUTION; INJECTION | 🇿🇼Zimbabwe | ROCHE PRODUCTS | active | Mar 2028 |
| PHESGO SOLUTION; INJECTION | 🇿🇼Zimbabwe | ROCHE PRODUCTS | active | Mar 2028 |
| PHESGO® 1200MG/600MG SI SC BTE(1FL X 15ML) ROCHE PHARMA Solution injectable SC | 🇲🇬Madagascar | ROCHE PHARMA (SCHWEIZ) AG | active | — |
| Phesgo 1200 mg/600 mg/15 mL Solution for injection | 🇳🇬Nigeria | — | active | — |
| PHESGO® 600MG/600MG SI SC BTE(1FL X 10ML) ROCHE PHARMA Solution injectable SC | 🇲🇬Madagascar | ROCHE PHARMA (SCHWEIZ) AG | active | — |
| Phesgo 600 mg/600 mg/10 mL Solution for injection | 🇳🇬Nigeria | — | active | — |
| PHESGO® 1200MG/600MG SI SC BTE(1FL X 15ML) ROCHE PHARMA Solution injectable SC | 🇲🇬Madagascar | ROCHE PHARMA (SCHWEIZ) AG | active | — |
| PHESGO® 600MG/600MG SI SC BTE(1FL X 10ML) ROCHE PHARMA Solution injectable SC | 🇲🇬Madagascar | ROCHE PHARMA (SCHWEIZ) AG | active | — |
PERTUZUMAB + TRASTUZUMAB in Africa — Regulatory Overview
PERTUZUMAB + TRASTUZUMAB is registered across 5 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Madagascar, Côte d'Ivoire, Ghana, Nigeria and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.